RDHL - RedHill shares rally 20% on positive data for two antiviral drugs
2023-12-20 11:06:15 ET
More on RedHill
- RedHill secures funding for Phase 2 study of COVID-19 treatment
- RedHill stock nearly doubles in value pre-market on a five-year FDA exclusivity grant
- Financial information for RedHill
For further details see:
RedHill shares rally 20% on positive data for two antiviral drugs